Friedrich von Bohlen und Halbach
Director/Board Member at HEIDELBERG PHARMA AG
Network origin in Friedrich von Bohlen und Halbach first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Swiss Federal Institute of Technology
62
| College/University | Other Consumer Services | 62 |
| Public Company | Pharmaceuticals: Major | 26 | |
| Public Company | Biotechnology | 16 | |
16
| Public Company | Pharmaceuticals: Major | 16 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.
16
| Subsidiary | Biotechnology | 16 |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.
11
| Subsidiary | Biotechnology | 11 |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany.
10
| Holding Company | Medical Specialties | 10 |
| Public Company | Pharmaceuticals: Major | 10 | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany.
7
| Holding Company | Biotechnology | 7 |
dievini Verwaltungs GmbH
3
| Private Company | 3 | |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The private company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany.
3
| Subsidiary | Investment Managers | 3 |
Febit, Inc.
3
| Subsidiary | 3 | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy.
3
| Private Company | Pharmaceuticals: Major | 3 |
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany.
3
| Holding Company | Medical/Nursing Services | 3 |
Cosmo Bioscience SpA
1
| Private Company | 1 | |
Wyss Translational Center Zurich
1
| Private Company | 1 | |
Innosource Ventures AG
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Friedrich von Bohlen und Halbach via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
| BASF SE | Chemicals: Major Diversified | Corporate Officer/Principal Corporate Officer/Principal | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| PAION AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TIGENIX NV | Medical Specialties | Chairman Chairman | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MEDIGENE AG | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Human Resources Officer Corporate Officer/Principal | |
| University of Freiburg | College/University | Graduate Degree Doctorate Degree | |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The private company is based in Haren, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chairman Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
| University of St. Gallen | College/University | Doctorate Degree Doctorate Degree | |
| RWTH Aachen University | College/University | Doctorate Degree Undergraduate Degree | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Director/Board Member Undergraduate Degree Doctorate Degree Doctorate Degree | |
| University of Mannheim | College/University | Doctorate Degree Undergraduate Degree | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree Doctorate Degree | |
| University of Milan | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Regensburg | College/University | Doctorate Degree Undergraduate Degree | |
J.F. Müller & Sohn AG
 J.F. Müller & Sohn AG Forest ProductsNon-Energy Minerals J.F. Müller & Sohn AG manufactures hardwood veneer, softwood veneer, and plywood. The company was founded by Friedrich Jacob Müller in 1795 and is headquartered in Hamburg, Germany. | Forest Products | Chairman Chairman | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| DZ Bank AG (Securities) | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director of Finance/CFO Director/Board Member | |
LTS LOHMANN Therapie-Systeme AG
 LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
| Université Catholique de Louvain | College/University | Chairman Doctorate Degree | |
German Cancer Research Center
 German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Hospital/Nursing Management | Corporate Officer/Principal Chief Administrative Officer | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
GEUDER AG
 GEUDER AG Medical SpecialtiesHealth Technology GEUDER AG manufactures ophthalmic surgical instruments and systems. Its products include eye specula, retractors, foreign body instruments, scissors, forceps, needle holders and sterilization containers and adapters. The company was founded by Hans Geuder, Sr. in 1951 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Sales & Marketing Chief Executive Officer | |
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Corporate Officer/Principal Director of Finance/CFO | |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Director/Board Member Director/Board Member Director/Board Member | |
Wilex, Inc.
 Wilex, Inc. Medical/Nursing ServicesHealth Services Part of Nuclea Biotechnologies, Inc., Wilex, Inc. develops medical diagnostic tests. The private company is based in Cambridge, MA. The CEOs of the company are Thomas Borcholte, Olaf G. Wilhelm. Wilex was acquired by Nuclea Biotechnologies, Inc. from Heidelberg Pharma AG on September 06, 2013. | Medical/Nursing Services | Director of Finance/CFO Chief Executive Officer | |
BePharBel Manufacturing SA
 BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology BePharBel Manufacturing SA manufactures and distributes pharmaceutical products. Its products include drugs, tuberculosis and food supplements and cosmetics. The company was founded on March 26, 2012 and is headquartered in Courcelles, Belgium. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
OncoDNA SA
 OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chairman Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
| INFLARX N.V. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Director of Finance/CFO Founder Founder Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Neovii Biotech GmbH
 Neovii Biotech GmbH BiotechnologyHealth Technology Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
BESIX Group NV
 BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Engineering & Construction | Chairman Director/Board Member |
Statistics
International
| Germany | 30 |
| United States | 10 |
| Belgium | 8 |
| Italy | 3 |
| Japan | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Finance | 4 |
| Health Services | 4 |
Operational
| Director/Board Member | 324 |
| Corporate Officer/Principal | 154 |
| Chairman | 90 |
| Chief Executive Officer | 85 |
| Director of Finance/CFO | 62 |
Most connected contacts
| Insiders | |
|---|---|
| Christof Hettich | 40 |
| Baron Jean Stéphenne | 36 |
| Douglas Williams | 25 |
| Hans Tanner | 24 |
| Peter Chambré | 23 |
| Craig Tooman | 22 |
| Hans-Christian Perle | 22 |
| Michael Halbherr | 22 |
| Mathias Hothum | 19 |
| Harald F. Stock | 17 |
| Peter Heinrich Krammer | 16 |
| Carsten Reinhardt | 16 |
| Roland Yves Siegwart | 16 |
| Gerald D. Cagle | 15 |
| Arnd Christ | 15 |
- Stock Market
- Insiders
- Friedrich von Bohlen und Halbach
- Company connections
